AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31727664 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotarix (third dose)
Number of subjects: 0
Study 31727664 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 28006991 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM-MSCs
Number of subjects: 30
Study 28006991 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM-MNCs
Number of subjects: 30
Study 28006991 — intervention group
Group type: COMPARATOR
Intervention: Control (sham procedure)
Number of subjects: 30
Study 25601979 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 453
Study 25601979 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 453
Study 22429586 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (eow) as continuous treatment
Number of subjects: 460
Study 22429586 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab 40 mg every other week (eow) after retreatment
Number of subjects: 460
Study 22429586 — intervention group
Group type: COMPARATOR
Intervention: Retreatment with adalimumab
Number of subjects: 460
Study 22429586 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab continuous treatment
Number of subjects: 460
Study 22016976 — intervention group
Group type: EXPERIMENTAL
Intervention: Method for calming the liver and suppressing Yang (Traditional Chinese Medicine)
Number of subjects: 48
Study 22016976 — intervention group
Group type: COMPARATOR
Intervention: Thiamazole tablets
Number of subjects: 48
Study 19845951 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-day cord cleansing with 4.0% chlorhexidine
Number of subjects: 0
Study 19845951 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day cord cleansing with 4.0% chlorhexidine
Number of subjects: 0
Study 19845951 — intervention group
Group type: COMPARATOR
Intervention: Promotion of dry cord care as recommended by WHO
Number of subjects: 0
Study 16903243 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625mg/day orally for 3 months
Number of subjects: 48
Study 16903243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 15560702 — intervention group
Group type: EXPERIMENTAL
Intervention: Head balance exercise (Group 2)
Number of subjects: 1565
Study 15560702 — intervention group
Group type: COMPARATOR
Intervention: No head balance exercise (Group 1)
Number of subjects: 1565
Study 10690131 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV) at 60, 100, 150, and 200 bpm (HFJV.p and HFJV.d)
Number of subjects: 12
Study 10690131 — intervention group
Group type: EXPERIMENTAL
Intervention: Valveless high frequency jet ventilator (VPP)
Number of subjects: 12
Study 10690131 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV)
Number of subjects: 12
Study 10690131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung model with variable compliance and resistance
Number of subjects: 12
Study 9177609 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB treatment (15 patients)
Number of subjects: 26
Study 9177609 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA treatment (11 patients)
Number of subjects: 26
Study 1683578 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 85
Study 1683578 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime plus metronidazole
Number of subjects: 85
Study 6123339 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 6123339 — intervention group
Group type: EXPERIMENTAL
Intervention: ORG NC 45
Number of subjects: 0
Study 6123339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 0
Study 30249435 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital clown-nurse during burn dressing change
Number of subjects: 50
Study 30249435 — intervention group
Group type: COMPARATOR
Intervention: Standard care without hospital clown (Control)
Number of subjects: 50
Study 27687613 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI increase
Number of subjects: 787
Study 27687613 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides increase
Number of subjects: 787
Study 27687613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose levels
Number of subjects: 787
Study 24354930 — intervention group
Group type: EXPERIMENTAL
Intervention: ePULab e-learning tool
Number of subjects: 100
Study 24354930 — intervention group
Group type: COMPARATOR
Intervention: Traditional on-campus class
Number of subjects: 100
Study 22722512 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0657 monotherapy (4-8 mg/d)
Number of subjects: 5
Study 22722512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 20102832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cover flow (collages of foods in a category)
Number of subjects: 104
Study 20102832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree view (food categories in a list)
Number of subjects: 104
Study 20102832 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-generated food categories
Number of subjects: 104
Study 20102832 — intervention group
Group type: EXPERIMENTAL
Intervention: Professionally generated food categories
Number of subjects: 104
Study 17659076 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer based sessions
Number of subjects: 55
Study 17659076 — intervention group
Group type: COMPARATOR
Intervention: Lecture based sessions
Number of subjects: 55
Study 16162046 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived social consensus feedback indicating more favorable attitudes toward obese people (Study 1)
Number of subjects: 315
Study 16162046 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived social consensus feedback from an in-group source (Study 2)
Number of subjects: 315
Study 16162046 — intervention group
Group type: COMPARATOR
Intervention: Consensus approach compared with other stigma reduction methods (Study 3)
Number of subjects: 315
Study 16162046 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about uncontrollable causes of obesity and supposed scientific prevalence of traits (Study 3)
Number of subjects: 315
Study 12113286 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg per day
Number of subjects: 20
Study 12113286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10892417 — intervention group
Group type: COMPARATOR
Intervention: Beta-agonists
Number of subjects: 0
Study 10892417 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin antagonists
Number of subjects: 0
Study 10892417 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide donors
Number of subjects: 0
Study 10892417 — intervention group
Group type: COMPARATOR
Intervention: Various approaches for secondary prevention
Number of subjects: 0
Study 8750221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) insulin infusion at 2 mU/kg‐1 min‐1
Number of subjects: 12
Study 8750221 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) insulin infusion at 1 mU/kg‐1 min‐1
Number of subjects: 12
Study 2025692 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence
Number of subjects: 63
Study 2025692 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled gambling
Number of subjects: 63
Study 2025692 — intervention group
Group type: COMPARATOR
Intervention: Uncontrolled gambling
Number of subjects: 63
Study 6358126 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose nimodipine therapy
Number of subjects: 35
Study 6358126 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine and verapamil
Number of subjects: 35
Study 30855740 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible duty-hour rules (no specified limits on shift length or mandatory time off)
Number of subjects: 63
Study 30855740 — intervention group
Group type: COMPARATOR
Intervention: Standard duty hours (as per ACGME guidelines)
Number of subjects: 63
Study 30855740 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible duty-hour rules
Number of subjects: 63
Study 30855740 — intervention group
Group type: COMPARATOR
Intervention: Standard duty hours
Number of subjects: 63
Study 29914785 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine
Number of subjects: 237
Study 29914785 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower concentration groups (0.0625%, 0.1%)
Number of subjects: 237
Study 29914785 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentrations
Number of subjects: 237
Study 29914785 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 237
Study 29914785 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction score 72 hours after delivery
Number of subjects: 237
Study 27477254 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused ESWT plus Isokinetic Exercise (IE)
Number of subjects: 30
Study 27477254 — intervention group
Group type: COMPARATOR
Intervention: Focused ESWT
Number of subjects: 30
Study 27128606 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose (SD) of GSK2018682 up to 24 mg
Number of subjects: 0
Study 27128606 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat dose (RD) of GSK2018682 up to 6 mg/day for 28 days
Number of subjects: 0
Study 27128606 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2018682
Number of subjects: 0
Study 27128606 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2018682 in fed state
Number of subjects: 0
Study 27128606 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2018682 RD of 6 mg
Number of subjects: 0
Study 22381223 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based antiseptic containing chlorhexidine gluconate (CHG)
Number of subjects: 0
Study 22381223 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-only antiseptics
Number of subjects: 0
Study 19818574 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 80
Study 19818574 — intervention group
Group type: COMPARATOR
Intervention: nPSV
Number of subjects: 80
Study 17464905 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with stress training (SBT)
Number of subjects: 30
Study 17464905 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting)
Number of subjects: 30
Study 17823517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream applied twice daily for 7 days
Number of subjects: 26
Study 17823517 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied twice daily for 7 days
Number of subjects: 26
Study 17823517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream
Number of subjects: 26
Study 17823517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 14707556 — intervention group
Group type: EXPERIMENTAL
Intervention: 546C88
Number of subjects: 797
Study 14707556 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 797
Study 11151289 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training program (cognitive-restructuring and problem-solving strategies)
Number of subjects: 0
Study 11151289 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8960377 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium 20 micrograms
Number of subjects: 12
Study 8960377 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium 40 micrograms
Number of subjects: 12
Study 8960377 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium 60 micrograms
Number of subjects: 12
Study 8960377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8960377 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (20-60 micrograms)
Number of subjects: 12
Study 1534729 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase treatment (9900 FCC units, 3 chewable tablets)
Number of subjects: 24
Study 1534729 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase treatment
Number of subjects: 24
Study 1534729 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 24
Study 6143968 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant DNA leucocyte interferon A
Number of subjects: 16
Study 6143968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30784673 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 2067
Study 30784673 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 2067
Study 30077803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT) skills group
Number of subjects: 54
Study 30077803 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy (PPT) group
Number of subjects: 54
Study 30077803 — intervention group
Group type: COMPARATOR
Intervention: DBT
Number of subjects: 54
Study 30077803 — intervention group
Group type: COMPARATOR
Intervention: PPT
Number of subjects: 54
Study 27017331 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training for 16 weeks
Number of subjects: 111
Study 27017331 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training for 56 weeks
Number of subjects: 111
Study 27017331 — intervention group
Group type: COMPARATOR
Intervention: Control group (no olfactory training)
Number of subjects: 111
Study 24812071 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention including monthly breastfeeding learning sessions, weekly text and voice messages, and participant-generated songs and dramas.
Number of subjects: 390
Study 24812071 — intervention group
Group type: COMPARATOR
Intervention: Control arm continued with the regular microcredit program.
Number of subjects: 390
Study 22250885 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐administered computer therapy targeting whole word production with error reduction strategies
Number of subjects: 0
Study 22250885 — intervention group
Group type: COMPARATOR
Intervention: Visuospatial sham computer program
Number of subjects: 0
Study 19281013 — intervention group
Group type: EXPERIMENTAL
Intervention: Back-rotation traction manipulation
Number of subjects: 86
Study 19281013 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (acupuncture, obturation, needle-knife)
Number of subjects: 86
Study 17229323 — intervention group
Group type: COMPARATOR
Intervention: 0 g alcohol (control)
Number of subjects: 51
Study 17229323 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g alcohol (one drink)
Number of subjects: 51
Study 17229323 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g alcohol (two drinks)
Number of subjects: 51
Study 16333887 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy with adjuvant propranolol (40 mg tds)
Number of subjects: 40
Study 16333887 — intervention group
Group type: COMPARATOR
Intervention: Injection sclerotherapy only
Number of subjects: 40
Study 16333887 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy with adjuvant propranolol
Number of subjects: 40
Study 16333887 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 12223437 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber group (13.5 g/day)
Number of subjects: 1208
Study 12223437 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber group (2.0 g/day)
Number of subjects: 1208
Study 12223437 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental fiber intake greater than 11.0 g/day
Number of subjects: 1208
Study 12223437 — intervention group
Group type: EXPERIMENTAL
Intervention: Total fiber intake greater than 30.3 g/day
Number of subjects: 1208
Study 9653495 — intervention group
Group type: EXPERIMENTAL
Intervention: FU-Plus-LV (400 mg/m2/day FU + 20 mg/m2/day LV for 5 days)
Number of subjects: 309
Study 9653495 — intervention group
Group type: COMPARATOR
Intervention: FU Alone (400 mg/m2/day FU)
Number of subjects: 309
Study 7858400 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion rate < 6.0 mg.kg‐1.h‐1
Number of subjects: 400
Study 7858400 — intervention group
Group type: COMPARATOR
Intervention: Propofol infusion rate > 6.0 mg.kg‐1.h‐1
Number of subjects: 400
Study 2915887 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil, adriamycin, and cyclophosphamide (FAC)
Number of subjects: 94
Study 2915887 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil, epirubicin, and cyclophosphamide (FEC)
Number of subjects: 94
Study 2915887 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC
Number of subjects: 94
Study 2915887 — intervention group
Group type: COMPARATOR
Intervention: FEC
Number of subjects: 94
Study 2915887 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC and FEC
Number of subjects: 94
Study 1149786 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlorizin
Number of subjects: 2
Study 1149786 — intervention group
Group type: COMPARATOR
Intervention: Control (lactase deficient subjects)
Number of subjects: 2
Study 31977699 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling therapy
Number of subjects: 14
Study 31033013 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg) in dim light (10 lux)
Number of subjects: 10
Study 31033013 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg) in bright light (2000 lux)
Number of subjects: 10
Study 31033013 — intervention group
Group type: COMPARATOR
Intervention: Placebo in dim light (10 lux)
Number of subjects: 10
Study 31033013 — intervention group
Group type: COMPARATOR
Intervention: Placebo in bright light (2000 lux)
Number of subjects: 10
Study 28760175 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 27
Study 28760175 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging
Number of subjects: 27
Study 28760175 — intervention group
Group type: COMPARATOR
Intervention: Stretching (Control)
Number of subjects: 27
Study 25640706 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid boluses of 0.9% saline
Number of subjects: 3170
Study 25640706 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid boluses of albumin
Number of subjects: 3170
Study 25640706 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion
Number of subjects: 3170
Study 25640706 — intervention group
Group type: COMPARATOR
Intervention: Control group (no transfusion)
Number of subjects: 3170
Study 24533998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 1910
Study 24533998 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education
Number of subjects: 1910
Study 22459236 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 246
Study 22459236 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 246
Study 18930209 — intervention group
Group type: EXPERIMENTAL
Intervention: LUVO plus laparoscopic myomectomy (LUVO+LM)
Number of subjects: 131
Study 18930209 — intervention group
Group type: COMPARATOR
Intervention: LUVO plus ultra-mini laparotomy (LUVO+UMLT-M)
Number of subjects: 131
Study 17131072 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 46
Study 17131072 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 46
Study 15184278 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/d
Number of subjects: 15
Study 15184278 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg/d
Number of subjects: 15
Study 15184278 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (various doses)
Number of subjects: 15
Study 12583942 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg salmeterol twice daily (n=372)
Number of subjects: 1465
Study 12583942 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 microg fluticasone twice daily (n=374)
Number of subjects: 1465
Study 12583942 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg salmeterol and 500 microg fluticasone twice daily (n=358)
Number of subjects: 1465
Study 12583942 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=361)
Number of subjects: 1465
Study 10561271 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert radiologists' interpretations of CT scans
Number of subjects: 59
Study 7532573 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-verbal patterns
Number of subjects: 9
Study 7532573 — intervention group
Group type: EXPERIMENTAL
Intervention: Word and word-like letter strings
Number of subjects: 9
Study 7532573 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-verbal stimuli
Number of subjects: 9
Study 7532573 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed class words
Number of subjects: 9
Study 7532573 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological matching
Number of subjects: 9
Study 1783346 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelofalk (a combination of smectite, aluminium hydroxide, and magnesium hydroxide)
Number of subjects: 97
Study 1783346 — intervention group
Group type: COMPARATOR
Intervention: Aluminium hydroxide antacid (control)
Number of subjects: 97
Study 7211892 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of medroxyprogesterone (MPG) daily for approximately one month
Number of subjects: 21
Study 7211892 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 21
Study 31398904 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching exercises three times per week for 6 weeks
Number of subjects: 27
Study 31398904 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching exercises three times per week for 6 weeks
Number of subjects: 27
Study 31398904 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching protocol)
Number of subjects: 27
Study 27571237 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide gel
Number of subjects: 27
Study 27571237 — intervention group
Group type: COMPARATOR
Intervention: 35% hydrogen peroxide gel
Number of subjects: 27
Study 26905220 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided heart failure treatment
Number of subjects: 258
Study 26905220 — intervention group
Group type: COMPARATOR
Intervention: Routine heart failure treatment (Control)
Number of subjects: 258
Study 26905220 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to BNP-guided therapy
Number of subjects: 258
Study 26905220 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-responders to BNP-guided therapy
Number of subjects: 258